All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Orbito-Ethmoidal Rhabdomyosarcoma in an Adult Patient: A Case Report

DOI: 10.4236/oalib.1106263, PP. 1-8

Subject Areas: Oncology

Keywords: Case Report, Rhabdomyosarcomas (RMS)

Full-Text   Cite this paper   Add to My Lib

Abstract

Rhabdomyosarcomas (RMS) is one of the most common sarcomas in children but rare in adults. It can occur in any anatomic location but most often presents in the head and neck region. Herewith, we report a rare case of primary orbito-ethmoidal rhabdomyosarcoma in a 29-year-old female. The patient underwent induction chemotherapy and achieved surprising results.

Cite this paper

Quang, N. T. , Anh, P. T. , Hang, H. T. and Anh, N. P. (2020). Orbito-Ethmoidal Rhabdomyosarcoma in an Adult Patient: A Case Report. Open Access Library Journal, 7, e6263. doi: http://dx.doi.org/10.4236/oalib.1106263.

References

[1]  Sultan, I., Qaddoumi, I., Yaser, S., et al. (2009) Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients. Journal of Clinical Oncology, 27, 3391. https://doi.org/10.1200/JCO.2008.19.7483
[2]  Little, D.J., Ballo, M.T., Zagars, G.K., et al. (2002) Adult Rhabdomyosarcoma: Outcome Following Multimodality Treatment. Cancer, 95, 377-388. https://doi.org/10.1002/cncr.10669
[3]  Amer, K.M., Thomson, J.E., Congiusta, D., et al. (2019) Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis. Journal of Orthopaedic Research, 37, 2226-2230. https://doi.org/10.1002/jor.24387
[4]  Li, F.P. and Fraumeni Jr., J.F. (1969) Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms. A Familial Syndrome? Annals of Internal Medicine, 71, 747-752. https://doi.org/10.7326/0003-4819-71-4-747
[5]  Hartley, A.L., Birch, J.M., Marsden, H.B., et al. (1988) Neurofibromatosis in Children with Soft Tissue Sarcoma. Pediatric Hematology and Oncology, 5, 7-16. https://doi.org/10.3109/08880018809031246
[6]  DeBaun, M.R. and Tucker, M.A. (1998) Risk of Cancer during the First Four Years of Life in Children from The Beckwith-Wiedemann Syndrome Registry. Journal of Pediatrics, 132, 398. https://doi.org/10.1016/S0022-3476(98)70008-3
[7]  Matsui, I., Tanimura, M., Kobayashi, N., et al. (1993) Neurofibromatosis Type 1 and Childhood Cancer. Cancer, 72, 2746. https://doi.org/10.1002/1097-0142(19931101)72:9<2746::aid-cncr2820720936>3.0.CO;2-W
[8]  Quezada, E. and Gripp, K.W. (2007) Costello Syndrome and Related Disorders. Current Opinion in Pediatrics, 19, 636-644. https://doi.org/10.1097/MOP.0b013e3282f161dc
[9]  Gripp, K.W., Scott Jr., C.I., Nicholson, L., et al. (2002) Five Additional Costello Syndrome Patients with Rhabdomyosarcoma: Proposal for a Tumor Screening Protocol. American Journal of Medical Genetics, 108, 80-87. https://doi.org/10.1002/ajmg.10241
[10]  Smith, A.C., Squire, J.A., Thorner, P., et al. (2001) Association of Alveolar Rhabdomyosarcoma with the Beckwith-Wiedemann Syndrome. Pediatric and Developmental Pathology, 4, 550-558. https://doi.org/10.1007/s10024001-0110-6
[11]  Shapiro, D.N., Sublett, J.E., Li, B., et al. (1993) Fusion of PAX3 to a Member of the Forkhead Family of Transcription Factors in Human Alveolar Rhabdomyosarcoma. Cancer Research, 53, 5108-5112.
[12]  Davis, R.J., D’Cruz, C.M., Lovell, M.A., et al. (1994) Fusion of PAX7 to FKHR by the Variant t(1;13)(p36;q14) Translocation in Alveolar Rhabdomyosarcoma. Cancer Research, 54, 2869-2872.
[13]  Months, S.R. and Raney, R.B. (1986) Rhabdomyosarcoma of the Head and Neck in Children: The Experience at the Children’s Hospital of Philadelphia. Medical and Pediatric Oncology, 14, 288-292. https://doi.org/10.1002/mpo.2950140508
[14]  Garnsey, L., Beltangady, M.S., Gehan, E., Ruymann, F., Webber, B., Hays, D.M., Crist, W.M., et al. (1990) Prognosis in Children with Rhabdomyosarcoma: A Report of the Intergroup Rhabdomyosarcoma Studies I and II. Intergroup Rhabdomyosarcoma Committee. Journal of Clinical Oncology, 8, 443-452. https://doi.org/10.1200/JCO.1990.8.3.443
[15]  Crist, W.M., Anderson, J.R., Meza, J.L., et al. (2001) Intergroup Rhabdomyosarcoma Study-IV: Results for Patients with Nonmetastatic Disease. Journal of Clinical Oncology, 19, 3091-3102. https://doi.org/10.1200/JCO.2001.19.12.3091
[16]  Raney, R.B., Walterhouse, D.O., Meza, J.L., et al. (2011) Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin with or without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients with Low-Risk EMBR. Journal of Clinical Oncology, 29, 1312-1318. https://doi.org/10.1200/JCO.2010.30.4469
[17]  Breneman, J., Meza, J., Donaldson, S.S., et al. (2012) Local Control with Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma: A Report from the Children’s Oncology Group D9602 Study. International Journal of Radiation Oncology, Biology, Physics, 83, 72. https://doi.org/10.1016/j.ijrobp.2011.06.2011
[18]  Arndt, C.A., Hawkins, D.S., Meyer, W.H., Sencer, S.F., Neglia, J.P. and Anderson, J.R. (2008) Comparison of Results of a Pilot Study of Alternating Vincristine/Doxorubicin/ Cyclophosphamide and Etoposide/Ifosfamide with IRS-IV in Intermediate Risk Rhabdomyosarcoma: A Report from the Children’s Oncology Group. Pediatric Blood & Cancer, 50, 33-36. https://doi.org/10.1002/pbc.21093
[19]  Arndt, C.A., Stoner, J.A., Hawkins, D.S., et al. (2009) Vincristine, Actinomycin, and Cyclophosphamide Compared with Vincristine, Actinomycin, and Cyclophos- phamide Alternating with Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children’s Oncology Group Study D9803. Journal of Clinical Oncology, 27, 5182-5188. https://doi.org/10.1200/JCO.2009.22.3768

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal